Arthritis Centers of Texas

Dallas, Texas 75246

0 studies enrolling now · 12 studies all time

What they study most

Arthritis, Rheumatoid, Dry Mouth Associated With Sjogren's Syndrome, Lupus Erythematosus, Systemic, Rheumatoid Arthritis, Xerostomia

Studies at this site

• Long Term Extension Study to Assess the Safety and Efficacy of Filgotinib in Adults With Rheumatoid Arthritis — Completed
• A Study of Ustekinumab in Participants With Active Systemic Lupus Erythematosus — Stopped early
• Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis — Completed
• Dose-finding Study of GLPG0634 as add-on to Methotrexate in Active Rheumatoid Arthritis Participants (DARWIN1) — Completed
• A Study to Evaluate the Safety of Rituximab Retreatment in Subjects With Systemic Lupus Erythematosus — Completed
• A Study of Ocrelizumab Compared to Placebo in Patients With Active Rheumatoid Arthritis Who Don't Have a Response to Anti-TNF-α Therapy (SCRIPT) — Stopped early
• A Safety and Efficacy Study of 552-02 in Subjects With Dry Mouth Associated With Sjogren's Syndrome — Completed
• A Study on The Safety of Administering Rituximab at A More Rapid Rate in Patients With Rheumatoid Arthritis — Completed
• Phase IIIB Switching From Intravenous to Subcutaneous Study — Completed
• Abatacept Versus Adalimumab Head-to-Head — Completed
• A Safety and Efficacy Study of LymphoStat-B™ (Monoclonal Anti-BLyS Antibody) in Subjects With Rheumatoid Arthritis (RA) — Completed
• A Continuation Trial for Subjects With Rheumatoid Arthritis That Have Completed Protocol LBRA01 — Stopped early